The effect of select nutrients on serum high-density lipoprotein cholesterol and apolipoprotein A-I levels.

@article{Mooradian2006TheEO,
  title={The effect of select nutrients on serum high-density lipoprotein cholesterol and apolipoprotein A-I levels.},
  author={Arshag D. Mooradian and Michael J Haas and Norman C. W. Wong},
  journal={Endocrine reviews},
  year={2006},
  volume={27 1},
  pages={
          2-16
        }
}
One of the factors contributing to the increased risk of developing premature atherosclerosis is low plasma concentrations of high-density lipoprotein (HDL) cholesterol (HDLc). Multiple potential mechanisms account for the cardioprotective effects of HDL and its main protein apolipoprotein A-I (apo A-I). The low plasma concentrations of HDL could be the result of increased fractional clearance and reduced expression of apo A-I. To this end, nutrients play an important role in modulating the… 
The Effect of Nutritional Supplements on Serum High-Density Lipoprotein Cholesterol and Apolipoprotein A-I
TLDR
The clinical relevance of the changes in HDL and apo A-I caused by nutrient supplementation needs to be tested in controlled clinical trials.
Therapies to Increase ApoA-I and HDL-Cholesterol Levels
TLDR
There is a continuing need for novel therapies that increase the biosynthesis of HDL, to inhibit the progression of and even bring about regression of atherosclerosis, and small molecule compounds that increaseThe production of endogenous ApoA-I would be attractive therapeutic agents for treating dyslipidemias.
Increasing apoA-I production as a target for CHD risk reduction.
The Effect of Glucosamine on Serum High Density Lipoprotein Cholesterol and Apolipoprotein AI Levels in People with Diabetes Mellitus
TLDR
It is suggested that glucosamine at commonly consumed doses does not have significant effects on glycemic control, lipid profile or levels of apolipoprotein AI in diabetic subjects after 2 weeks of supplementation.
Dyslipidemia in Type 2 Diabetes: Prevalence, Pathophysiology, and Management
TLDR
Although the evidence for clinical utility of combination of statins with fibrates or nicotinic acid in reducing cardiovascular events remains inconclusive, the preponderance of evidence suggests that a subgroup who have high triglycerides and low HDL-c levels may benefit from combination therapy of statin and fibrate.
The Rise and Fall “ing” of the HDL Hypothesis
TLDR
It is possible that HDL quality and function is optimal only when de novo synthesis of apo A-I occurs, and inhibition of turnover of HDL with currently available agents yields HDL molecules that are ineffective in reverse cholesterol transport.
Obesity‐related Changes in High‐density Lipoprotein Metabolism
TLDR
There is a considerable heterogeneity of plasma lipid profile in overweight and obese people, and the emergence of glucose intolerance or a genetic predisposition to familial combined hyperlipidemia will further modify the plasma lipid phenotype in obese people.
Sex-specific interaction between APOE genotype and carbohydrate intake affects plasma HDL-C levels: the Strong Heart Family Study
TLDR
Evidence for a sex-specific effect of APOE and the macronutrient carbohydrate on circulating levels of HDL-C, TG, and ApoA-1 is examined in a sample of 326 male and 423 female participants of the Strong Heart Family Study.
Functional foods for dyslipidaemia and cardiovascular risk prevention
TLDR
A food can be regarded as ‘functional’ if it can demonstrate a beneficial efficacy on one or more target functions in the body in a convincing way and improve the state of health and wellbeing and/or reduce the risk of disease.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 161 REFERENCES
Effects of nicotinic acid therapy on plasma high density lipoprotein subfraction distribution and composition and on apolipoprotein A metabolism.
TLDR
The data suggest that the effects of nicotinic acid on the HDL subfraction distribution may be mediated via (a) net transfer of ApoA-I from HDL(3) to HDL(2) and (b) a reduction in ApOA-II synthesis.
High-density lipoprotein metabolism: Molecular targets for new therapies for atherosclerosis
TLDR
The next decade will witness the transition from preclinical studies to clinical trials of a variety of new therapies targeted toward HDL metabolism and atherosclerosis.
Dietary cholic acid lowers plasma levels of mouse and human apolipoprotein A-I primarily via a transcriptional mechanism.
TLDR
It is suggested that dietary cholate regulates plasma levels of apoA-I primarily by a transcriptional mechanism via a putative bile acid response element involving a negative regulator of api-I, and partly by an unidentified post-transcriptional mechanism.
Exploiting the Vascular Protective Effects of High-Density Lipoprotein and Its Apolipoproteins: An Idea Whose Time for Testing Is Coming, Part I
TLDR
The structure/function of HDL is reviewed and means of enhancing the levels and/or function of HDL and its apolipoproteins for vascular protection are explored.
Differential effects of dietary fat on the tissue-specific expression of the apolipoprotein A-I gene: relationship to plasma concentration of high density lipoproteins.
TLDR
Data indicate that dietary polyunsaturated fat can selectively alter the expression of the apoA-I gene in a tissue-specific manner.
Dietary Fat Elevates Hepatic ApoA-I Production by Increasing the Fraction of Apolipoprotein A-I mRNA in the Translating Pool (*)
TLDR
The reported elevation of HDL-C by a HF/HC diet is attributable, in part, to an increase in the hepatic production of hapoA-1, and the hepatocellular processes associated with this induction are defined, to suggest a post-transcriptional mechanism that does not involve mRNA stability.
Diabetic Dyslipidemia: Basic Mechanisms Underlying the Common Hypertriglyceridemia and Low HDL Cholesterol Levels
TLDR
Increased free fatty acid transport in plasma, a common abnormality in insulin-resistant states, may be the underlying driving force for the two common lipid abnormalities seen in diabetes.
High-density lipoproteins and atherosclerosis.
  • D. Rader
  • Biology
    The American journal of cardiology
  • 2002
Dietary fat saturation affects apolipoprotein AII levels and HDL composition in postmenopausal women.
TLDR
A palmolein diet increased TC and HDL cholesterol compared with oleic acid sunflower oil diet; however, the increase in Apo AII but not in Apolipoprotein AII suggests the impairment of reverse cholesterol transport and potentially an increase in CHD risk.
...
1
2
3
4
5
...